Optimization of the Extraction Conditions and Simultaneous Quantification by RP-LC of Six Alkaloids in Evodiae Fructus

被引:10
作者
Meng-yao Zhao
Xiu-wei Yang
机构
[1] Peking University,State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences
来源
Chromatographia | 2008年 / 67卷
关键词
Column liquid chromatography; Quantification; Orthogonal array design; Alkaloids; Evodiae fructus;
D O I
暂无
中图分类号
学科分类号
摘要
A reversed phase liquid chromatographic (LC) method coupled with DAD (250 nm) has been developed and validated for simultaneous quantification of six alkaloids, dehydroevodiamine (1), wuzhuyuamide-I (2), 5-hydroxyrutaecarpine (3), 14-formyldihydrorutaecarpine (4), evodiamine (5) and rutaecarpine (6), in 12 batches evodiae fructus [the dried, unripe fruits of Evodia rutaecarpa (Juss.) Benth. or E. rutaecarpa (Juss.) Benth. var. officinalis (Dode) Huang, E.rutaecarpa (Juss.) Benth. var. bodinieri (Dode) Huang] as a traditional Chinese medicine. The method was carried out by a C18 column (250 × 4.6 mm) with a gradient mobile phase of methanol, acetonitrile, and phosphoric acid–triethylamine–buffer solution. The contents of 1–6 in the evodiae fructus could easily be determined within 70 min. The experimental results were satisfactory for the intra-day and inter-day precision and accuracy of the method for simultaneous determination. The linear calibration ranges of 1–6 were 40–1,000, 20–500, 1–100, 10–500, 40–1,000 and 80–1,000 μg mL−1. The recoveries of 1–6 were 97.43–103.73% with RSDs from 0.21 to 1.99%. The limits of detection for 1–6 were 2.0, 2.0, 0.1, 1.0, 5.0 and 5.0 μg mL−1, and the limits of quantification were 6.6, 6.6, 0.3, 3.3, 16.5 and 16.5 μg mL−1. The method was successfully applied to the quantification of six alkaloids in the evodiae fructus.
引用
收藏
页码:543 / 550
页数:7
相关论文
共 94 条
[1]  
Du LJ(1998)undefined Pharmacol Clin Chin Mater Med 14 4-6
[2]  
Sun H(2001)undefined Planta Med 67 244-248
[3]  
Li M(2002)undefined Planta Med 68 705-709
[4]  
Su XL(1988)undefined Pharmacol Clin Chin Mater Med 4 9-14
[5]  
Wang ZM(2002)undefined J Chin Mater Med 27 862-866
[6]  
Xiao SY(1982)undefined Am J Chin Med 10 75-77
[7]  
Kobayashi Y(1996)undefined J Nat Prod 59 374-378
[8]  
Hoshikume K(2000)undefined Microbiol Immuno 44 9-15
[9]  
Nakano Y(2001)undefined Eur J Pharmaco 413 221-225
[10]  
Yokoo Y(2005)undefined Eur J Med Chem 40 305-313